Please provide your email address to receive an email when new articles are posted on . AIM-MASH AI Assist is the first AI drug development tool to be qualified by the FDA. The tool is designed to ...

Madrigal Pharmaceuticals' Rezdiffra generated sales of $287 million in the third quarter for a 35% sequential jump from Q2. In just its fifth full quarter on the market, the world’s first treatment ...

EXCLUSIVE: The 1962 song “Monster Mash,” which has become an annual Halloween +hit, is becoming an animated movie at Miramax. Miramax CEO Jonathan Glickman, who has been behind such haunted hits as ...

“Monster Mash” was originally written as a parody of several pop fads that have faded away, but the song is an American novelty song that lives on like a vampire. In the early 1960s two cultural ...

Note: The U.S. Food and Drug Administration (FDA) doesn’t approve supplements for safety or effectiveness. Always talk with your healthcare professional about whether a supplement fits your health ...

Cile Steward, 8, has been missing since the floods hit the camp on July 4. Less than three months after devastating floods tragically killed 27 people at Camp Mystic in Kerr County, Texas, the camp ...

Jack Daniel’s is one of the most popular whiskey brands in the world, to the point where the famed No. 7 label can seem ubiquitous on bar and retail shelves. But the Tennessee brand’s latest release ...

“We continue to evaluate plans to rebuild Camp Mystic Guadalupe River." Camp Mystic announced plans to reopen one site of its summer camp a year after flash flooding killed 27 campers and counselors ...

Two months after catastrophic flooding killed 27 girls and counselors at Camp Mystic, the famed Texas camp plans to reopen – shocking some family members who still don’t know where their loved one is.

Jack Daniel’s Distillery Series is a collection of whiskeys that highlights the use of different mashbills, secondary maturations, and production methods, and is only available in limited numbers in ...

Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — Roche on Thursday said it would buy 89bio, the maker of an ...